🚀 ProPicks AI Hits +34.9% Return!Read Now

UPDATE 2-European shares rise on vaccine hopes; Brexit talks eyed

Published 01/12/2020, 10:30
Updated 01/12/2020, 18:12
© Reuters.
UK100
-
CRDI
-
IPN
-
STOXX
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE leads gains in Europe, up 1.9%
* Unicredit slides after CEO steps down
* French, German factory activity slips in November
* Still chances of Brexit without a trade deal - British
Minister

(Updates to close)
By Susan Mathew
Dec 1 (Reuters) - European shares made a positive start to
the month on Tuesday following record-breaking gains in
November, with optimism around a coronavirus vaccine
strengthening the case for economic recovery.
Hopes the pandemic might end soon came from Pfizer PFE.N
and BioNTech BNTX.O seeking emergency approval from the
European regulator of their vaccine candidate, neck-and-neck
with Moderna MRNA.O , which announced it would ask the
regulator to recommend conditional approval for its shot.
MKTS/GLOB
After a day's dip when investors took some profits, the
pan-European STOXX 600 index .STOXX was back in the black, up
0.7%. The index ended November with gains of nearly 14%.
Gains were largely broad-based with basic materials .SXPP
in the lead as robust China factory activity data buoyed copper
and iron ore prices. Defensive plays such as healthcare .SXDP
and utilities .SX6P lagged. IRONORE/ MET/L
After marking its best month in over three decades, London's
blue-chip index .FTSE rallied 1.9% to post its best day in
three weeks, propelled by data showing improving confidence and
the UK's fastest growth in factory activity in three years. .L
Elsewhere in Europe, impacts of lockdowns to curb the spread
of COVID-19 continued to be felt, with manufacturing activity in
France and Germany slowing in November. "More stringent restrictions and tougher fiscal
conversations should keep growth (in Europe) subdued, even if
there is catch up potential," said Esty Dwek, head of global
market strategy at Natixis Investment Managers Solutions, adding
that expectations are for a weak first quarter.
Some European nations are set to cautiously lift
coronavirus-induced curbs put in place to control the spread of
the novel coronavirus, while the European Central Bank's meeting
next week will be eyed for policy easing especially after
Tuesday's data showing dropping inflation. "Europe should be one of the beneficiaries of the reopening
trade, as indices remain well below the U.S. and well below
pre-crisis levels, Dwek said. "The EU Recovery Fund and
additional ECB support should help with sentiment, supporting a
recovery in financials among others."
On the Brexit front, a senior British minister said on
Tuesday there was still a chance of a turbulent exit from the
European Union without a trade deal, as talks had snagged on
fishing, governance rules and dispute resolution. Among stocks, Italian lender Unicredit SpA CRDI.MI logged
its worst day since March, sliding 8% after it said Chief
Executive Officer Jean Pierre Mustier will step down in April
next year over disagreements with the board.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.